George Kemble - Net Worth and Insider Trading

George Kemble Net Worth

The estimated net worth of George Kemble is at least $390,500 dollars as of 2024-09-20. George Kemble is the Executive Chairman of Sagimet Biosciences Inc and owns about 118,693 shares of Sagimet Biosciences Inc (SGMT) stock worth over $390,500. Details can be seen in George Kemble's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George Kemble has not made any transactions after 2024-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of George Kemble

To

George Kemble Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George Kemble owns 1 companies in total, including Sagimet Biosciences Inc (SGMT) .

Click here to see the complete history of George Kemble’s form 4 insider trades.

Insider Ownership Summary of George Kemble

Ticker Comapny Transaction Date Type of Owner
SGMT Sagimet Biosciences Inc 2024-07-23 director

George Kemble Latest Holdings Summary

George Kemble currently owns a total of 1 stock. George Kemble owns 118,693 shares of Sagimet Biosciences Inc (SGMT) as of July 23, 2024, with a value of $390,500.

Latest Holdings of George Kemble

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGMT Sagimet Biosciences Inc 2024-07-23 118,693 3.29 390,500

Holding Weightings of George Kemble


George Kemble Form 4 Trading Tracker

According to the SEC Form 4 filings, George Kemble has made a total of 2 transactions in Sagimet Biosciences Inc (SGMT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sagimet Biosciences Inc is the sale of 23,625 shares on July 23, 2024, which brought George Kemble around $74,891.

Insider Trading History of George Kemble

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George Kemble Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

George Kemble Ownership Network

Ownership Network List of George Kemble

No Data

Ownership Network Relation of George Kemble

Insider Network Chart

George Kemble Owned Company Details

What does Sagimet Biosciences Inc do?

Who are the key executives at Sagimet Biosciences Inc?

George Kemble is the director of Sagimet Biosciences Inc. Other key executives at Sagimet Biosciences Inc include General Counsel and CCO Elizabeth Rozek , director & President & CEO David Happel , and 10 percent owner New Enterprise Associates 13 Lp .

Sagimet Biosciences Inc (SGMT) Insider Trades Summary

Over the past 18 months, George Kemble made 2 insider transaction in Sagimet Biosciences Inc (SGMT) with a net sale of 37,687. Other recent insider transactions involving Sagimet Biosciences Inc (SGMT) include a net purchase of 14,290 shares made by David Happel , a net purchase of 29,338 shares made by New Enterprise Associates 13 Lp , and a net purchase of 46,875 shares made by Beth C Seidenberg .

In summary, during the past 3 months, insiders sold 56,958 shares of Sagimet Biosciences Inc (SGMT) in total and bought 0 shares, with a net sale of 56,958 shares. During the past 18 months, 57,620 shares of Sagimet Biosciences Inc (SGMT) were sold and 91,165 shares were bought by its insiders, resulting in a net purchase of 33,545 shares.

Sagimet Biosciences Inc (SGMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sagimet Biosciences Inc Insider Transactions

No Available Data

George Kemble Mailing Address

Above is the net worth, insider trading, and ownership report for George Kemble. You might contact George Kemble via mailing address: Sagimet Biosciences Inc., 155 Bovet Rd., Ste. 303, San Mateo Ca 94402.

Discussions on George Kemble

No discussions yet.